KOSUNI KOREA
Korean News in English
Technology

KAIST Discovers Molecular Switches: Diagnosing and Solving Technical Challenges

Published October 14, 2026 · 2 views
KAIST Discovers Molecular Switches: Diagnosing and Solving Technical Challenges

KAIST 스위치 발견: 기술적 문제의 진단과 해결 과정

KAIST research teams have identified 'molecular switches' that regulate cell growth signals, 'neural switches' in the brain, and 'RNA switches' related to aging—world firsts with potential contributions to next-generation cancer treatments, anti-aging therapies, obesity suppression, and dementia symptom relief. Notably, a 'molecular switch' capable of reverting cancer cells to normal cells and 'switch-type CAR-T' applied to breast cancer treatment have opened new possibilities for solid tumor therapy.

Molecular Switches Regulating Cell Growth Signals

KAIST researchers have identified the world's first 'molecular switch' that turns cell growth signals on and off, presenting a new target for next-generation cancer treatments. This technology reveals a novel mechanism controlling cancer cell growth, with potential to address resistance issues seen in current cancer drugs. Notably, research results published by July 2026 include the world's first identification of an 'anti-cancer switch' called '13-HODE.'

Cell growth signal regulation technology allows for easily turning on and off cell signals within the body, similar to an electrical switch. This is expected to open new possibilities for solid tumor treatments like breast cancer therapy. Developed through a joint research effort between KAIST and the National Cancer Center, the 'cancer cell return-to-normal switch' secured core technology in September 2025, with multiple related research findings reported by 2026.

Read More Related Articles

You can view similar articles on this topic at once.

View Related Articles

Neural Switches in the Brain and Dementia Relief

KAIST has identified 'neural switches' in the brain, offering an explanation for dementia patients' tendency to remain stuck in past memories. This research was published on May 17, 2026, detailing the identification of a 'brain switch' that retrieves recent memories. The phenomenon of dementia patients remaining stuck in past memories is linked to how specific neural circuits operate in the brain, and regulating this switch could help alleviate dementia symptoms.

The research on identifying brain switches began in earnest in 2025 and saw related findings published by May 2026. This is expected to contribute to developing new treatments for dementia patients. KAIST's identification of neural switches goes beyond merely explaining the phenomenon of remaining stuck in past memories, providing a practical approach toward dementia relief.

RNA Switches for Aging Delay and Obesity Suppression

KAIST has identified aging-related 'RNA switches'—the world's first—which have raised expectations for anti-aging therapies. This research was published on January 25, 2026, including the discovery of a protein switch that blocks obesity and the elucidation of fat cell generation mechanisms. RNA switches regulate the expression of specific genes during cellular aging processes, offering ways to delay aging.

Obesity suppression technology was developed by identifying a 'switch' that halts fat cell production. This switch clarifies the mechanism for stopping fat cell growth, with related research findings reported on January 25 and 26, 2026. KAIST has presented new directions for obesity prevention and treatment through these technologies.

Combining AI with Switch Technology

KAIST is applying AI technology to switch research to solve various problems. In August 2021, they completed guidelines addressing bias in skin cancer diagnosis AI datasets, contributing to solving AI's time perception issues. This research helps AI operate more accurately in medical fields and is expected to improve the reliability of future data analysis.

On January 25, 2025, KAIST laid groundwork for regulating and treating metabolic diseases, with related research continuing through January 25, 2026. This demonstrates that switch technology can be applied beyond cellular-level issues to comprehensive health management.

Research Outcomes and Future Outlook

KAIST's 'switch' research has been concentratedly published between 2025 and 2026, with particular attention on the molecular switch for cancer cell return-to-normal status and 'switch-type CAR-T' applied to breast cancer treatment. In September 2025, KAIST collaborated with the National Cancer Center to develop core technology for the 'cancer cell return-to-normal switch,' enabling a technique that reverts cancer cells back to normal cells from their initial stage of occurrence.

On January 25, 2026, KAIST announced the discovery of an obesity-blocking protein switch and the elucidation of fat cell generation mechanisms, presenting a new approach for obesity treatment. Additionally, brain 'neural switch' research was completed on May 17, 2026, opening possibilities for developing new treatments for dementia patients.

KAIST 스위치 발견: 기술적 문제의 진단과 해결 과정

KAIST's Switch Technology and Clinical Application

KAIST researchers have proposed next-generation cancer treatment targets through the 'molecular switch' regulating cell growth signals. This identifies a mechanism for reverting cancer cells to normal cells, with related research findings published between 2025 and 2026. Notably, the world's first identification of an anti-cancer switch called '13-HODE' was announced on June 4, 2026, potentially helping overcome resistance issues seen in current cancer drugs.

Through joint research with the National Cancer Center, KAIST successfully developed technology to revert cancer cells to normal cells, securing core technology in September 2025. This is evaluated as opening new possibilities for solid tumor treatment. 'Switch-type CAR-T,' first applied to breast cancer treatment, allows more precise cell regulation compared to traditional CAR-T therapy.

Social Significance of Research Outcomes

KAIST's switch research extends beyond scientific discovery to hold social significance. Anti-aging technology could lead to new treatments for an aging population, while obesity suppression technology may contribute to preventing chronic diseases. Dementia relief research is particularly valuable for elderly health management.

Notably, the application of 'switch-type CAR-T' in breast cancer treatment has been evaluated as a groundbreaking development in solid tumor therapy. While traditional therapies focused on directly attacking cancer cells, switch technology enables more precise treatment by regulating cellular mechanisms itself.

Research Outcomes and Future Prospects

KAIST's switch research was concentratedly published between 2025 and 2026, with particular attention on the 'cancer cell return-to-normal switch' and 'brain neural switches.' These studies are expected to transition from scientific discovery to practical clinical application.

In the future, KAIST will focus on developing new drugs and treatments based on these switch technologies. Particularly, obesity-blocking protein switches identified in research published on January 25, 2026, present a novel approach in the field of obesity treatment, expected to contribute to future metabolic disease therapies.

Key Information to Verify

KAIST's 'switch' research has been concentratedly published between 2025 and 2026, with particular attention on molecular switches for cancer cell return-to-normal status and neural switches in the brain. Notably, 'switch-type CAR-T' applied to breast cancer treatment has opened new possibilities for solid tumor therapy, having secured core technology through collaboration with the National Cancer Center in September 2025.

Aging delay research was conducted through RNA switch identification, while obesity suppression technology followed from the discovery of a fat cell generation-blocking switch. Related research findings were published on January 25 and 26, 2026, presenting new directions for obesity treatment.

Frequently Asked Questions

How does the cancer cell return-to-normal switch work?

The molecular switch regulates the mechanism that reverts cancer cells to normal cells. When activated, it suppresses cancer cell growth and facilitates their conversion back to normal cells, potentially helping address resistance issues with current cancer drugs.

What contribution can brain neural switch research make to dementia treatment?

This research helps regulate neural circuits in the brain that cause dementia patients to remain stuck in past memories. By activating specific memory circuits through this switch, new treatments for alleviating dementia symptoms have become possible.

How does the obesity-blocking protein switch work?

The switch clarifies a mechanism that halts fat cell production. When activated, it suppresses fat cell growth, and is expected to be effective in preventing and treating obesity.

Frequently Asked Questions

KAIST's 'switch' research has evolved from scientific discovery into innovative technologies applicable to real life. By controlling cell growth signals, identifying brain neural circuits, delaying aging, and suppressing obesity, it opens new possibilities across various fields. With future clinical applications expected to benefit more patients, these studies are not only scientific achievements but also contribute significantly to social value.

View More in the Same Category

Continue exploring similar topics.

View Category Articles

FAQ

How does the cancer cell return-to-normal switch work?

The molecular switch regulates the mechanism that reverts cancer cells to normal cells. When activated, it suppresses cancer cell growth and facilitates their conversion back to normal cells, potentially helping address resistance issues with current cancer drugs.

What contribution can brain neural switch research make to dementia treatment?

This research helps regulate neural circuits in the brain that cause dementia patients to remain stuck in past memories. By activating specific memory circuits through this switch, new treatments for alleviating dementia symptoms have become possible.

How does the obesity-blocking protein switch work?

The switch clarifies a mechanism that halts fat cell production. When activated, it suppresses fat cell growth, and is expected to be effective in preventing and treating obesity.

Korean Source

This article is an English localization of a Korean-language report from BlogScore. Original: KAIST 스위치 발견: 기술적 문제의 진단과 해결 과정